Feeling your feelings about regulatory decisions

After yesterday's announcement by CMS regarding coverage of an Alzheimer's therapy (link to the article below), there's likely to be a lot of feelings. For me, I'm frustrated that we're ONLY at this point, with so few therapies available to treat the disease.

Let's chat about it.

https://www.nytimes.com/2022/01/11/health/aduhelm-medicare-alzheimers.html?campaign_id=60&emc=edit_na_20220111&instance_id=0&nl=breaking-news&ref=cta&regi_id=62186417&segment_id=79377&user_id=4c4636ee37676ef5a6c604df8a045d74